PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
// Carmen Oi-ning Leung 1 , Carmen Chak-lui Wong 1,2 , Dorothy Ngo-yin Fan 1 , Alan Ka-lun Kai 1 , Edmund Kwok-kwan Tung 1 , Iris Ming-jing Xu 1 , Irene Oi-lin Ng 1,2 and Regina Cheuk-lam Lo 1,2 1 Department of Pathology, The University of Hong Kong, Hong Kong, China 2 State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China Correspondence to: Regina Cheuk-lam Lo, email: // Irene Oi-lin Ng, email: // Keywords : PIM1, HCC, metastasis Received : October 30, 2014 Accepted : February 18, 2015 Published : March 12, 2015 Abstract Hepatocellular carcinoma (HCC) is characteristically one of the most rapidly proliferating tumors which outgrows functional blood supply and results in regional oxygen deprivation. Overexpression of PIM1, a serine/threonine kinase, has been identified recently in human cancers. Knowledge on PIM1 in HCC is however, scarce. By immunohistochemical analysis on 56 human primary HCC samples, we observed overexpression of PIM1 in 39% of the cases. In two independent cohorts of paired primary and extra-hepatic metastatic HCC tissues, PIM1 expression was higher (p=0.002) in the extra-hepatic metastatic HCC tissues as compared with the corresponding primary HCCs. PIM1 was markedly up-regulated in multiple HCC cell lines in hypoxic condition (1% O 2 ) versus normoxia (20% O 2 ). Silencing of PIM1 suppressed HCC cell invasion in vitro as compared to non-target control, and decreased HCC cell proliferation in vitro and tumor growth and metastatic potential in vivo . Knockdown of PIM1 significantly reduced glucose uptake by HCC cells and was associated with decreased levels of p-AKT and key molecules in the glycolytic pathway. Taken together, PIM1 is up-regulated by hypoxia in HCC and promotes tumor growth and metastasis through facilitating cancer cell glycolysis. Targeting PIM1 may have potential role in the management of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 1×
“O2 acts as a substrate for the prolyl hydroxylation of HIF-1/2α [2], which subsequently enables Von-Hippel-Lindau (VHL) to mediate ubiquitinproteasomal degradation [3].”
BackgroundTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
Lu, X., & Kang, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1360 · Cited by 723
Hayashi, M., Sakata, M., Takeda, T., Yamamoto, T., Okamoto, Y., Sawada, K., Kimura, A., Minekawa, R., Tahara, M., Tasaka, K., et al. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05599 · Cited by 234 · cited 5×
“GLUT-1 is overexpressed in HCC tissues and facilitates hepatocarcinogenesis [29, 30].”
BackgroundInfluential
Cited by
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Lin, A., Giuliano, C. J., Palladino, A., John, K. M., Abramowicz, C., Yuan, M. L., Sausville, E. L., Lukow, D. A., Liu, L., Chait, A. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8412 · Cited by 754
PIM kinases: From survival factors to regulators of cell motility
Santio, N. M., & Koskinen, P. J. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.016 · Cited by 69
Malone, T., Schäfer, L., Simon, N., Heavey, S., Cuffe, S., Finn, S., Moore, G., & Gately, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107454 · Cited by 33
Tan, H., Leung, C. O., Chan, K. K., Ho, D. W., Leung, M., Wong, C., Ng, I. O., & Lo, R. C. (2019) · International Journal of Cancer · doi:10.1002/ijc.32248 · Cited by 22
Self-citation
Metadata
- Authors
- Leung, C. O.-N., Wong, C. C.-L., Fan, D. N.-Y., Kai, A. K.-L., Tung, E. K.-K., Xu, I. M.-J., Ng, I. O.-L., & Lo, R. C.-L.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-03-12
- Volume
- 6
- Issue
- 13
- Pages
- 10880-10892
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1500418465
- Cited by
- 70
- References
- 6
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. https://app.cochat.ai/papers/10.18632/oncotarget.3534
- The paper
- Leung, C. O.-N., Wong, C. C.-L., Fan, D. N.-Y., Kai, A. K.-L., Tung, E. K.-K., Xu, I. M.-J., Ng, I. O.-L., & Lo, R. C.-L. (2015). PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. Oncotarget. https://doi.org/10.18632/oncotarget.3534
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.